UT researchers are developing antibody-based therapies to treat a wide range of cancers, such as glioblastomas, breast cancer, and pancreatic cancer. We are also identifying monoclonal antibodies to treat infections caused by viruses such as the Yellow Fever Virus and developing anti-biofilm agents to prevent bacterial infections.
